Liu and colleagues characterized spike- and RBD-specific MBC upon inactivated SARS-CoV-2 vaccine administration, showing that MBC persisted despite a decreasing trend over a 5-month time frame between second and third immunization, and that the third dose significantly increased the antigen-specific MBC ( 51 ).
← all excerpts
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2.
1
—
—